Robert DelAversano

Insider Reports History

Location
217 W. Main Street, Somerville, NJ
Signature
/s/ Robert DelAversano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert DelAversano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ONCOSEC MEDICAL Inc VP, Finance Common Stock 1.01K $1.38K $1.37 Feb 9, 2023 Direct
Grace Therapeutics, Inc. Principal Financial Officer Stock Option (Right to Buy) 20.1K Apr 14, 2025 Direct

Insider Reports Filed by Robert DelAversano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRCE Grace Therapeutics, Inc. Apr 14, 2025 1 $0 4 Apr 16, 2025 Principal Financial Officer
ACST Acasti Pharma Inc. May 6, 2024 1 $0 4 May 8, 2024 Principal Financial Officer
ACST Acasti Pharma Inc. Jan 5, 2024 0 $0 3 Jan 8, 2024 Vice President, Finance
ONCS ONCOSEC MEDICAL Inc Feb 9, 2023 1 -$55 4 Feb 9, 2023 VP, Finance
ONCS ONCOSEC MEDICAL Inc Nov 4, 2022 1 -$105 4 Nov 4, 2022 VP, Finance
ONCS ONCOSEC MEDICAL Inc Aug 5, 2022 1 -$202 4 Aug 5, 2022 VP, Finance
ONCS ONCOSEC MEDICAL Inc May 6, 2022 1 -$227 4 May 6, 2022 VP, Finance
ONCS ONCOSEC MEDICAL Inc Feb 9, 2022 1 -$360 4 Feb 11, 2022 VP, Finance
ONCS ONCOSEC MEDICAL Inc Nov 1, 2021 1 -$600 4 Nov 3, 2021 VP, Finance
ONCS ONCOSEC MEDICAL Inc Aug 1, 2021 1 -$898 4 Aug 3, 2021 VP, Finance
ONCS ONCOSEC MEDICAL Inc Jun 28, 2021 1 $0 4 Jun 29, 2021 Vice President, Finance